| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 3, 2026
Following recent U.S. Food and Drug Administration (FDA) labeling approval, European label milestone reinforces Medtronic leadership in advancing aortic care based on clinical evidence supporting the treatment of ruptured abdominal aortic aneurysms (rAAA).
-
Sep 2, 2026
GALWAY, Ireland, September 2, 2026 – Medtronic (NYSE: MDT), a global leader in healthcare technology announced that the Centers for Medicare and Medicaid Services (CMS) has granted a New...
-
Aug 5, 2026
Lower viscosity formulation designed to enable more distal penetration with 1-minute shake time
-
Jul 17, 2026
New 11-bed facility at Apollo Jubilee Hills to feature integrated Acute Care & Monitoring technologies and serve as a real-world clinical innovation hub for Medtronic R&D.
-
Jun 17, 2026
New, enhanced visualization†, seamless streaming, retrospective recording, and other advanced features to support the clinical need to intubate with first-pass success‡,1,2